NCI to Fund Consortium to Characterize Lesions at Molecular, Cellular Level | GenomeWeb

NEW YORK (GenomeWeb) – The National Cancer Institute will provide up to $4.5 million next year to fund research teams performing omics studies to characterize tumor lesions discovered through screening, with the aim of better predicting which lesions are progressive and require interventions and which are indolent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.